Rhoen Klinikum AGWBO:RHK +0.71%74 ROE % is 3.83% as of Mar. 2026, which is 21% above its 10-year median of 3.17. GuruFocus rates WBO:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.49. The stock has 3 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 58.95% on this metric.
The historical rank and industry rank for Rhoen Klinikum AG's ROE % or its related term are showing as below:
WBO:RHK'
s ROE % Range Over the Past 10 Years
Min: 0.12 Med: 3.17 Max: 5.18
Current: 3.05
During the past 13 years, Rhoen Klinikum AG's highest ROE % was 5.18%. The lowest was 0.12%. And the median was 3.17%.
WBO:RHK's ROE % is ranked worse than 58.95% of 626
companies
in the Healthcare Providers & Services industry
Industry Median: 5.805
vs WBO:RHK: 3.05
Rhoen Klinikum AG (WBO:RHK) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Rhoen Klinikum AG ROE % Related Terms
Rhoen Klinikum AG ROE % Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's ROE % distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Rhoen Klinikum AG (WBO:RHK) has a ROE % of 3.83% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Rhoen Klinikum AG and its competitors. This is 21% above median its historical median of 3.17. Over the past decade, Rhoen Klinikum AG's ROE % has ranged from 0.12 to 5.18. According to the industry distribution chart, Rhoen Klinikum AG ranks #369 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 58.9%.
Is Rhoen Klinikum AG's ROE % too high?
Rhoen Klinikum AG's current ROE % of 3.83% is 21% above median its 10-year median of 3.17. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 5.18. The Healthcare Providers & Services industry median ROE % is 5.81. Rhoen Klinikum AG's value of 3.83% is 34% below this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #369 out of 626 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #369 out of 626 companies for ROE %. This places Rhoen Klinikum AG in the lower half of its industry. The industry median ROE % is 5.81. Rhoen Klinikum AG's value of 3.83% is 34% below this benchmark. Historically, Rhoen Klinikum AG's own ROE % has ranged from 0.12 to 5.18 over the past decade. While the company's 10-year median is 3.17 vs. the industry median of 5.81, Rhoen Klinikum AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current ROE % of 3.83% is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current ROE % is 3.83%, which is 21% above median its own 10-year median of 3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current ROE % of 3.83%. The stock's GF Value™ is €13.49, compared to a current price of €14.10 — trading 4.5% above its estimated fair value. The current ROE % is 3.83%, which is 21% above median its 10-year median of 3.17 and 34% below the Healthcare Providers & Services industry median of 5.81. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current ROE % is 3.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued.
The current stock price of €14.10 is trading 4.5% above its estimated GF Value™ of €13.49.
Key valuation signals for WBO:RHK:
ROE %: 3.83% (21% above median its 10-year median of 3.17)
GF Value™: €13.49 vs. price of €14.10 (4.5% above fair value)
Industry Position: 34% below the Healthcare Providers & Services median (#369 of 626)
No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score
Get the complete analysis for WBO:RHK
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:RHK has been successfully added to your 
